Investigating Metabolomic and Transcriptomic Signatures of Metabolic Dysfunction in Antipsychotic-naïve Patients
Year: 2022
Type: dissertation
Abstract: Psychosis spectrum disorders (PSDs) are characterized by metabolic dysfunction, arising from intrinsic and external factors, including antipsychotic (AP) treatment. Transcriptomics and metabolomics may help explore underlying causes of the metabolic comorbidity. The thesis comprises two studies. In study one, peripheral transcriptomic datasets of AP-naïve first-episode psychosis patients, early dysglycemia patients, along with hypothalamic and hippocampal datasets of central insulin perturbation rodent models were meta-analyzed to identify overlapping gene expression signatures. Overlapping gene expression signatures included pathways of endoplasmic reticulum stress, mitochondrial dysfunction, lipid metabolism, inflammation, and neuroplasticity. In study two, 25 AP-naïve cases and 6 controls underwent metabolomic and metabolic measures at baseline. Cases were followed over 12 weeks of AP treatment. Fatty acids distinguished AP-naïve cases from controls. Baseline adrenic acid was higher for cases who gained weight. Transcriptomics and metabolomics may identify biomarkers of metabolic dysfunction intrinsic to PSDs and predict individuals at risk for AP-induced weight gain.
Source: TSpace (University of Toronto)
Author: Lee, Jiwon
Institution: University of Toronto
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: psychosis spectrum disorders, antipsychotic-naive patients, metabolic dysfunction, antipsychotic-induced weight gain, first-episode psychosis, dysglycemia, insulin resistance, hypothalamic gene expression, hippocampal gene expression, endoplasmic reticulum stress, mitochondrial dysfunction, lipid metabolism, inflammation, neuroplasticity, fatty acids, adrenic acid, biomarkers, rodent models
Open Access status: green
OpenAlex ID: W7132873724
